Patents by Inventor Brian Patrick Finan

Brian Patrick Finan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs and uses thereof
    Patent number: 11840560
    Abstract: Prodrug compounds of GLP-1/GIP receptor co-agonists are provided wherein the GLP-1/GIP receptor co-agonists have been modified by the linkage of a dipeptide to the GLP-1/GIP receptor co-agonist through an amide bond. The prodrugs disclosed herein have extended half-lives and are converted to the active GLP-1/GIP receptor co-agonist at physiological conditions through a non-enzymatic reaction driven by chemical instability.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: December 12, 2023
    Assignee: Novo Nordisk A/S
    Inventors: Patrick James Knerr, Brian Patrick Finan
  • GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS
    Publication number: 20230391845
    Abstract: The invention relates to peptides and derivatives thereof that are GLP-1/GIP/Glucagon receptor triple agonists and their medical use in treatment and/or prevention of obesity, diabetes, and/or liver diseases are described.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Inventors: Patrick James Knerr, Brian Patrick Finan, Yantao He, Richard Dimarchi, Fa Liu, Bhavesh Premdjee
  • PRODRUGS AND USES THEREOF
    Publication number: 20230227521
    Abstract: Prodrug compounds of GLP-1/GIP receptor co-agonists are provided wherein the GLP-1/GIP receptor co-agonists have been modified by the linkage of a dipeptide to the GLP-1/GIP receptor co-agonist through an amide bond. The prodrugs disclosed herein have extended half-lives and are converted to the active GLP-1/GIP receptor co-agonist at physiological conditions through a non-enzymatic reaction driven by chemical instability.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 20, 2023
    Inventors: Patrick James Knerr, Brian Patrick Finan
  • CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY
    Publication number: 20230120597
    Abstract: Peptide co-agonists of the human GLP-1 and GIP receptors suitable for oral delivery, including long-acting derivatives, and their medical use in treatment and/or prevention of obesity, diabetes, and/or liver diseases are described.
    Type: Application
    Filed: November 4, 2022
    Publication date: April 20, 2023
    Applicant: Novo Nordisk A/S
    Inventors: Patrick James Knerr, Brian Patrick Finan, Richard DiMarchi